Publications (2)8.72 Total impact
-
Article: Treatment of multifocal Bowen's disease in immunocompromised women with surgery and topical imiquimod.
[show abstract] [hide abstract]
ABSTRACT: In human immunodeficiency virus (HIV)-infected women, Bowen's disease may be difficult to treat successfully with surgery alone. Imiquimod cream, effective in treating Bowen's disease in healthy women, may be a useful postsurgical treatment in immunocompromised women. Two HIV-infected women had both Bowen's disease and severe cervical dysplasia. In both cases, Bowen's disease, but not cervical dysplasia, recurred after surgical treatment. When treated with topical 5% imiquimod cream twice weekly for 4 months, 70-80% reduction in lesions were observed in both patients. Follow-up biopsies of remaining lesions were vulvar intraepithelial neoplasia 1. Imiquimod cream, in combination with surgical treatment, may be an appropriate strategy for treatment of Bowen's disease in HIV-infected and other immunocompromised women.Obstetrics and Gynecology 02/2012; 119(2 Pt 2):442-4. · 4.73 Impact Factor -
Article: Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.
[show abstract] [hide abstract]
ABSTRACT: Female long-term survivors of allogeneic hematopoietic stem cell transplantation (allo-HSCT) incur a significant burden of late effects. Genital graft-versus-host disease (GVHD), human papillomavirus (HPV) reactivation, ovarian failure and infertility, sexual dysfunction, and osteoporosis are concerns that can significantly impact quality of life. This review examines the risk, pathogenesis, clinical presentation, and implications of these common complications. Recommendations are provided for evaluation and management of these late effects and other obstetric and gynecologic issues that may arise in this patient population.Seminars in Hematology 01/2012; 49(1):83-93. · 3.99 Impact Factor